ES-62 is unable to modulate Toxoplasma gondii-driven Th1 responses and pathology

K. N. Couper, W. Chen, K. M. Houston, W. Harnett, Lawrence L. Johnson

    Research output: Contribution to journalArticlepeer-review

    Abstract

    ES-62, a filarial nematode-derived anti-inflammatory immunomodulator, was administered to mice in an attempt to prevent pathology associated with Toxoplasma gondii infection. The nematode product was shown to elevate mitogen and T. gondii-specific IL-10 production but was unable to inhibit Th1 responses. Consequently ES-62 could not prevent Th1 generated immunopathology. © 2005 Blackwell Publishing Ltd.
    Original languageEnglish
    Pages (from-to)147-150
    Number of pages3
    JournalParasite Immunology
    Volume27
    Issue number4
    DOIs
    Publication statusPublished - Apr 2005

    Keywords

    • ES-62
    • Immunomodulation
    • Toxoplasma gondii

    Fingerprint

    Dive into the research topics of 'ES-62 is unable to modulate Toxoplasma gondii-driven Th1 responses and pathology'. Together they form a unique fingerprint.

    Cite this